$ACRX..$9.20 here. The clinical data looks pretty solid on this stock. images.investorshub.advfn.com/images/uploads/2014/7/17/ngxucACRX-Improving_Acute_Pain_Management.JPG images.investorshub.advfn.com/images/uploads/2014/7/17/drbfbACRX-Zalviso_Phase_3_Program.JPG